Jeffrey Chodakewitz is CMO & VP at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 26 open-market trades across 1 company since 2014, most recently 2026-06-22.
CIK 0001610876
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 26 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL | 2018-02-12 | 2018-02-14 | $150.94 | $1.1M | +4.7% | +10.9% | -1.8% |
| VRTX | SELL | 2018-02-05 | 2018-02-07 | $161.08 | $659K | +3.6% | +13.5% | -4.5% |
| VRTX | SELL | 2018-02-01 | 2018-02-05 | $166.65 | $782K | +5.4% | +11.5% | -2.1% |
| VRTX | SELL | 2018-01-16 | 2018-01-17 | $156.93 | $351K | +6.9% | +2.8% | +5.5% |
| VRTX | SELL | 2018-01-02 | 2018-01-03 | $151.85 | $756K | +1.5% | +8.2% | +3.2% |
| VRTX | SELL | 2017-11-02 | 2017-11-06 | $144.72 | $1.5M | -0.7% | -7.9% | +4.1% |
| VRTX | SELL | 2017-10-31 | 2017-10-31 | $145.05 | $8.7M | +0.9% | -2.1% | +13.4% |
| VRTX | SELL | 2017-10-31 | 2017-10-31 | $144.80 | $6.5M | +0.9% | -2.1% | +13.4% |
| VRTX | SELL | 2017-10-16 | 2017-10-18 | $155.05 | $393K | -3.3% | -4.6% | +0.7% |
| VRTX | SELL | 2017-10-02 | 2017-10-04 | $151.55 | $951K | +1.1% | -2.0% | -0.1% |
| VRTX | SELL | 2017-08-03 | 2017-08-04 | $154.21 | $385K | -0.8% | +4.2% | -5.0% |
| VRTX | SELL | 2017-08-02 | 2017-08-04 | $154.89 | $62K | -0.8% | +4.2% | -5.0% |
| VRTX | SELL | 2017-08-02 | 2017-08-04 | $154.17 | $831K | -0.8% | +4.2% | -5.0% |
| VRTX | SELL | 2017-07-21 | 2017-07-21 | $161.12 | $886K | -2.9% | -8.2% | -4.8% |
| VRTX | SELL | 2017-07-19 | 2017-07-21 | $160.96 | $7.5M | -2.9% | -8.2% | -4.8% |
| VRTX | SELL | 2017-07-17 | 2017-07-19 | $129.74 | $136K | -5.1% | -7.4% | -3.1% |
| VRTX | SELL | 2017-07-03 | 2017-07-06 | $127.80 | $879K | +2.3% | +21.1% | +18.1% |
| VRTX | SELL | 2017-06-21 | 2017-06-23 | $132.87 | $1.4M | -4.0% | +24.1% | +13.6% |
| VRTX | SELL | 2017-06-01 | 2017-06-05 | $126.87 | $1.3M | -4.1% | -0.3% | +22.9% |
| VRTX | SELL | 2017-05-02 | 2017-05-04 | $121.05 | $2.2M | +1.3% | +11.7% | +35.2% |
| VRTX | SELL | 2017-04-05 | 2017-04-07 | $114.00 | $914K | +1.4% | -0.5% | +11.1% |
| VRTX | SELL | 2017-04-03 | 2017-04-05 | $108.71 | $411K | +0.5% | +0.6% | +13.1% |
| VRTX | SELL | 2017-03-29 | 2017-03-31 | $106.65 | $2.9M | +5.4% | +10.7% | +16.7% |
| VRTX | SELL | 2017-02-13 | 2017-02-15 | $87.67 | $898K | +1.1% | +2.6% | +31.8% |
| VRTX | SELL | 2017-02-01 | 2017-02-03 | $85.74 | $163K | +3.7% | +5.4% | +35.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.